Summary To date, the dosing of sugammadex is based on real body weight without taking fat content into account. We compared the reversal of profound rocuronium-induced neuromuscular blockade in morbidly obese patients using doses of sugammadex based on four different weight corrections. One hundred morbidly obese patients, scheduled for laparoscopic bariatric surgery under propofolsufentanil anaesthesia, were randomly assigned four groups: ideal body weight; ideal body weight + 20%; ideal body weight + 40%; and real body weight. Patients received sugammadex 2 mg.k
Background:Despite the increasing numbers of obese patients undergoing elective surgery, there is a ...
Class III obese (body mass index 40 kg/m2) patients, now regularly encountered clinically, have inc...
Copyright © 2014 Shigeaki Otomo et al.This is an open access article distributed under theCreativeCo...
Abstract Background and objectives: The weight parameters for use of sugammadex in morbidly obese p...
Background. The obese patients have differences in body composition, drug distribution, and metaboli...
Background. The obese patients have differences in body composition, drug distribution, and metaboli...
Objective We investigated the efficacy and safety of sugammadex doses calculated using corrected bod...
Background and objectives: The weight parameters for use of sugammadex in morbidly obese patients st...
Background: Sugammadex is a selective relaxant binding agent for antagonism of prolonged rocuronium-...
International audienceIntroduction: Sugammadex is the first molecule able to antagonize steroidal mu...
Obesity has become a global health problem, reaching epidemic proportions in developed countries. Ne...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Complete and reliable neuromuscular reversal is important to successful anaesthetic recovery in the ...
Aim: In this study, we aimed to investigate the pharmacodynamic effects of rocuronium when dosed acc...
Background: Obesity changes body composition including fat free mass (FFM), regarded as the “pharmac...
Background:Despite the increasing numbers of obese patients undergoing elective surgery, there is a ...
Class III obese (body mass index 40 kg/m2) patients, now regularly encountered clinically, have inc...
Copyright © 2014 Shigeaki Otomo et al.This is an open access article distributed under theCreativeCo...
Abstract Background and objectives: The weight parameters for use of sugammadex in morbidly obese p...
Background. The obese patients have differences in body composition, drug distribution, and metaboli...
Background. The obese patients have differences in body composition, drug distribution, and metaboli...
Objective We investigated the efficacy and safety of sugammadex doses calculated using corrected bod...
Background and objectives: The weight parameters for use of sugammadex in morbidly obese patients st...
Background: Sugammadex is a selective relaxant binding agent for antagonism of prolonged rocuronium-...
International audienceIntroduction: Sugammadex is the first molecule able to antagonize steroidal mu...
Obesity has become a global health problem, reaching epidemic proportions in developed countries. Ne...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Complete and reliable neuromuscular reversal is important to successful anaesthetic recovery in the ...
Aim: In this study, we aimed to investigate the pharmacodynamic effects of rocuronium when dosed acc...
Background: Obesity changes body composition including fat free mass (FFM), regarded as the “pharmac...
Background:Despite the increasing numbers of obese patients undergoing elective surgery, there is a ...
Class III obese (body mass index 40 kg/m2) patients, now regularly encountered clinically, have inc...
Copyright © 2014 Shigeaki Otomo et al.This is an open access article distributed under theCreativeCo...